CLPBY COLOPLAST SPON ADS EACH REPR 0.1 OD SHS
- 12.530
- +0.350+2.87%
COLOPLAST SPON ADS EACH REPR 0.1 OD SHS News
Coloplast A/S - Invitation to Coloplast's Meet the Management Event on 6 June 2024 (Gentle Reminder)
Coloplast Expands Its Luja Portfolio With Next Generation Catheter for Women
COLOPLAST SPON ADS EACH REPR 0.1 OD SHS To Go Ex-Dividend On May 17th, 2024 With 0.07203 USD Dividend Per Share
May 9th - $COLOPLAST SPON ADS EACH REPR 0.1 OD SHS(CLPBY.US)$ is trading ex-dividend on May 17th, 2024. Shareholders of record on May 20th, 2024 will receive 0.07203 USD dividend per share on May
Coloplast (CLPBY.US): The 2024 Q2 financial report achieved revenue of US$959.1 million, previous value of US$873.6 million; earnings per share were US$0.08, compared to US$0.08 previously.
Coloplast (CLPBY.US): The 2024 Q2 financial report achieved revenue of US$959.1 million, previous value of US$873.6 million; earnings per share were US$0.08, compared to US$0.08 previously.
Coloplast Strengthens Ostomy Care Portfolio With Three Significant Product Launches
Coloplast A/S - Allocation of Share Options
Coloplast A/S - Interim Financial Report, Q1 2023/24
Coloplast A/S - Q1 2023/24 Earnings Release - Invitation for Conference Call on 9 February 2024 at 11.00am CET
Coloplast A/S Goes Ex-dividend Tomorrow
Coloplast Target Raised to DKK925 From DKK830 by Jefferies
Coloplast Target Raised to DKK925 From DKK830 by Jefferies
COLOPLAST SPON ADS EACH REPR 0.1 OD SHS To Go Ex-Dividend On December 8th, 2023 With 0.23266 USD Dividend Per Share
November 17th - $COLOPLAST SPON ADS EACH REPR 0.1 OD SHS(CLPBY.US)$ is trading ex-dividend on December 8th, 2023. Shareholders of record on December 11th, 2023 will receive 0.23266 USD dividend pe
Coloplast's Kerecis Buy Is Strategically Positive -- Market Talk
1135 GMT - Coloplast's acquisition of Kerecis is a strategic positive but will likely drive low single digit percentage consensus EPS dilution, Citi analysts Veronika Dubajova and Giang H Nguyen say i
Coloplast to Acquire Wound Care Firm Kerecis for $1.3B
Coloplast Raises Long-Term Organic Growth Guidance to 8%-10% From 7%-9%
Coloplast Raises Long-Term Organic Growth Guidance to 8%-10% From 7%-9%
Coloplast: Kerecis Has Developed Tech That Uses Fish Skin to Aid Wound Healing
Coloplast: Kerecis Has Developed Tech That Uses Fish Skin to Aid Wound Healing
Coloplast: Kerecis Is Biologics Wound Care Company
Coloplast: Kerecis Is Biologics Wound Care Company
Coloplast Agrees to Buy Kerecis For up to $1.3 Billion
Coloplast Agrees to Buy Kerecis For up to $1.3 Billion
COLOPLAST SPON ADS EACH REPR 0.1 OD SHS To Go Ex-Dividend On May 19th, 2023 With 0.07398 USD Dividend Per Share
May 13th - $COLOPLAST SPON ADS EACH REPR 0.1 OD SHS(CLPBY.US)$ is trading ex-dividend on May 19th, 2023. Shareholders of record on May 22nd, 2023 will receive 0.07398 USD dividend per share on May
Short Volatility Alert: Coloplast
On Tuesday, shares of Coloplast (OTC:CLPBY) experienced volatile short activity. After the activity, the stock price went up +0.59% to $13.18. The overall sentiment for CLPBY has been Bullish. The sig
Coloplast Target Cut to DKK880 From DKK1,150 by Jefferies
Coloplast Target Cut to DKK880 From DKK1,150 by Jefferies
Analysis
Price Target
No Data
